Tags Pharma

Tue 23 Aug 2022

Using Zeptomics for hit discovery

Learn more about the performance of ZeptoHit, the hit prediction algorithm of Zeptomics

Wed 11 May 2022

A new AI/ML approach for ligand identification

Only 1% of compound to protein interactions are currently known. We are on a mission to predict the remaining 99%.

Mon 22 May 2023

Pitch and Meet at the Tech.eu Summit

Kantify has been selecting to pitch at the Tech.eu Summit 2023 and will present Zeptomics, its solution for AI powered small molecule discovery

Fri 10 Mar 2023

Portrait in BECI Magazine, Brussels Business

In the March Edition of Brussels Business, a 2 page portrait is dedicated to our CEO and our team

Fri 03 Mar 2023

Upcoming talk: in silico drug discovery and animal testing

Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"

Mon 17 Oct 2022

Kantify & Mcule harness data to accelerate drug discovery

Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction

Wed 20 Jul 2022

Fragile X Syndrome: Innovative Approaches to Finding a Cure

Join the talk of our CTO at this cornerstone online event of the Fragile-X patient and research communityt

Mon 30 May 2022

Targeted Protein Degradation : Kantify at Proteocure event

Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure

Fri 19 Mar 2021

Kantify announces its new drug discovery technology

Kantify announces ZeptoNet, its new Virtual screening technology of small molecules

Tue 16 Mar 2021

Kantify at the Belgian AI Week 2021

Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.